International Journal of Celiac Disease最新文献_第3页

Any Time Laparoscopic Cholecystectomy in Moderate to Severe Acute Cholecystitis without Septic Shock 无感染性休克的中重度急性胆囊炎随时腹腔镜胆囊切除术

International Journal of Celiac Disease Pub Date : 2021-11-12 DOI: 10.12691/ijcd-9-3-1

Bhavin B Vasavada, H. Patel

引用次数: 0

In Memory of Professor Marsh NM: The Researcher who Understood and Lived Celiac Disease 纪念Marsh NM教授:了解并生活在乳糜泻中的研究者

International Journal of Celiac Disease Pub Date : 2021-11-12 DOI: 10.12691/ijcd-9-3-6

A. Lerner

引用次数: 0

Appreciation of the Quality of Life of Patients with Atopic Dermatitis. Clinical and Laboratory Study 特应性皮炎患者生活质量的评价。临床及化验研究

International Journal of Celiac Disease Pub Date : 2021-11-12 DOI: 10.12691/ijcd-9-3-8

E. Duca, M. Pascal, G. Sur, Remus Gaga, L. Sur

引用次数: 0

More Than Celiac Disease - Five Gluten-induced Pathologies 不仅仅是乳糜泻——五种麸质引起的疾病

International Journal of Celiac Disease Pub Date : 2021-11-12 DOI: 10.12691/ijcd-9-3-7

Maria Lucia Sur, M. Pascal, Remus Gaga

引用次数: 0

Drug-induced Collagenous Sprue: A Reversible Small Bowel Mucosal Disorder 药物诱导的胶原性口疮:一种可逆的小肠黏膜紊乱

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-6

H. Freeman

引用次数: 0

Antibiotic-Resistant Bacteria in Water and Fish: A Risk to Human Health 水和鱼中的耐抗生素细菌:对人类健康的威胁

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-2

M. Zaky, S. M. E. Toubar, Ahmed Samy El-Shafey

引用次数: 1

An Example to Follow In the COVID-19 Pandemic: Together For Celiac Disease Patients 在COVID-19大流行中遵循的一个例子:共同为乳糜泻患者服务

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-1

M. O. F. Barriguete

引用次数: 0

Nonresponsive Celiac Disease Treated with a Unique Functional Medical Approach 用独特的功能性医学方法治疗无反应性乳糜泻

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-7

T. O'bryan, A. Lerner

{"title":"Nonresponsive Celiac Disease Treated with a Unique Functional Medical Approach","authors":"T. O'bryan, A. Lerner","doi":"10.12691/IJCD-9-2-7","DOIUrl":"https://doi.org/10.12691/IJCD-9-2-7","url":null,"abstract":"A 16-year-old boy with nonresponsive celiac disease (NRCD), dermatitis herpetiformis, short stature, and failure to thrive, presented to this Functional Medicine practitioner because he had exceedingly high tissue transglutaminase (tTG) antibodies and poor growth, despite 10 months on a meticulous gluten-free diet (GFD). Immunological testing showed elevated antibody production against multiple peptides of wheat, food antigens, intestinal barrier dysfunction, lipopolysaccharide (LPS) antibodies, and polyreactive autoimmune reactions. An elimination diet, nutraceutical protocols to modulate the microbiome, address intestinal permeability, lower inflammation, and remove underlying bacterial infection were initiated. Global anti-inflammatory lifestyle modifications were recommended. Within 3 months of treatment, the patient’s tTG antibodies decreased by 14% for the first time since strict gluten elimination. Within 15 months, tTG IgG antibodies were nearly normal at 1.61 (0.03-1.60, ELISA Index). Test results improved dramatically in tandem with clinical progress. On a GFD and after initiating and maintaining these dietary and lifestyle changes, he gained 12 inches and 40 pounds. To our knowledge, this is the first published case of complete reversal of NRCD and failure to thrive by addressing endotoxin and lifestyle outside of a GFD.","PeriodicalId":13927,"journal":{"name":"International Journal of Celiac Disease","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89039262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Awareness of Celiac Disease among the General Public in Saudi Arabia 沙特阿拉伯公众对乳糜泻的认识

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-4

M. Alhussain

{"title":"Awareness of Celiac Disease among the General Public in Saudi Arabia","authors":"M. Alhussain","doi":"10.12691/IJCD-9-2-4","DOIUrl":"https://doi.org/10.12691/IJCD-9-2-4","url":null,"abstract":"Background: Celiac disease (CD) is an immune-mediated systemic disorder triggered by dietary gluten and is considered one of the most common lifelong food-related disorders worldwide. The knowledge of CD among the general public in Saudi Arabia remains limited. Therefore, we aimed to assess the awareness and knowledge of CD among the general public in Saudi Arabia. Methods: A cross-sectional online survey including members of the general public was conducted in Saudi Arabia. The survey included questions assessing the public’s awareness about CD, gluten sensitivity, and peanut allergy, as well as celiac disease-related knowledge. Results: From a total of 1230 responses received, 76.7% (95% confidence interval [CI], 74.0%–79.4%) were females, 42.0% (95% CI, 37.7–46.3) were aged between 31–45 years, and 64.3% (95% CI, 61.0%–67.6%) had Bachelor’s degree. Less than half of the participants had heard of CD (48.4%; 95% CI, 44.4%–52.4%), but the majority had heard of peanut allergy (80.1%; 95% CI, 77.6%–82.6%) and gluten sensitivity (72.4%; 95% CI, 69.5%–75.3%). The prevalence of CD was estimated incorrectly by more than 80% of participants. Other questions on participants’ knowledge associated with CD were answered “Do not know” by the majority. Females demonstrated a greater awareness of CD, peanut allergy, and gluten sensitivity, and had a higher percentage of correct responses to questions related to CD than males. Conclusion: This study highlights the need to increase the awareness and knowledge of CD, especially in the recognition of its symptoms. Educational efforts toward increasing the awareness of the general public about CD could help optimize its diagnosis and management.","PeriodicalId":13927,"journal":{"name":"International Journal of Celiac Disease","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73138026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Antibiotic Resistance in Acute Cholecystitis Graded According to Tokyo Guidelines 2018: The First Prospective Study 根据2018年东京指南分级的急性胆囊炎抗生素耐药性:第一项前瞻性研究

International Journal of Celiac Disease Pub Date : 2021-05-18 DOI: 10.12691/IJCD-9-2-3

H. Patel, B. Vasavada

{"title":"Antibiotic Resistance in Acute Cholecystitis Graded According to Tokyo Guidelines 2018: The First Prospective Study","authors":"H. Patel, B. Vasavada","doi":"10.12691/IJCD-9-2-3","DOIUrl":"https://doi.org/10.12691/IJCD-9-2-3","url":null,"abstract":"Introduction: Single-dose antibiotics are recommended for laparoscopic cholecystectomy, for symptomatic gall stones. However, very few studies are there for subgroup grade-2 and grade-3 cholecystitis according to Tokyo guidelines 2018. Material and methods: We retrospectively analysed outcomes of our protocol of no post-operative antibiotics in grade-2 and grade 3 (moderate to severe) acute cholecystitis according to Tokyo guidelines. We perform laparoscopic cholecystectomies within the first 24 hours of presentation to us without considering time since attack if the patient is not in septic shock where we follow survival sepsis guidelines and also perform percutaneous cholecystostomy. All the data were prospectively analysed. Statistical evaluation was done using SPSS version 21(IBM). Results: We performed 101 laparoscopic cholecystectomies between April 2016 to January 2019. We prefer single dose pre-operative antibiotic (third-generation cephalosporins) in all laparoscopic cholecystectomies and no post-operative antibiotics. A total of 74 patients were having grade 2 or grade 3 cholecystitis. 64 patients were having grade 2 and 9 patients were having grade 3 cholecystitis. One patient was having grade 3 cholecystitis and was having septic shock so he was managed with percutaneous cholecystostomy and according to survival sepsis protocol and lap choly was done after 72 hours and hence excluded from the study. Out of 73 patients included in the study, 2 patients were converted to open; in two patients we performed lap subtotal cholecystectomy due to a difficult calot triangle. Out of this only 1 patient developed port site infection and two patient developed biloma which was managed by percutaneous drainage. All patients were discharged the same day or the next day. Only two patients with biloma were readmitted. Rest all of the patients had an uneventful recovery. Conclusion: Post-operative antibiotics are unnecessary even in grade-2, grade-3 acute cholecystitis without septic shock according to Tokyo guidelines.","PeriodicalId":13927,"journal":{"name":"International Journal of Celiac Disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85198981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0